Aging is a major risk factor for chronic illnesses, including cardiovascular disease, cancer, diabetes, and neurodegenerative diseases like Alzheimer’s and Parkinson’s. While industrialization and modern medicine have extended average life expectancy in the past century, this progress has led to an epidemic of age-related diseases, which contributes to the global burden of chronic illness. Understanding…
Dustin Sposato
Today, a coalition of leaders across philanthropy, industry, academia, and government unveiled the Vision for American Science and Technology (VAST)—a strategic framework to reignite U.S. leadership in scientific discovery and innovation. As global competition intensifies, VAST offers a bold, actionable roadmap to ensure American science remains at the forefront of progress.VAST outlines key priorities,…
Cancer is a leading cause of death worldwide, and while significant progress has been made in recent years, we still don’t understand its complex mechanisms and how best to target its diverse forms. Unravelling the intricate genetic and molecular interactions involved in cancer development and progression, identifying novel targets for therapy, and refining early detection…
Philanthropic funding for emerging infectious disease research has steadily increased by about 10% annually between 2014-2019 in response to epidemics around the globe, such as MERS, Ebola, Zika, and Chikungunya. As the world scrambled to control the SARS-CoV-2 pandemic (COVID-19), philanthropic funding in the emerging infectious disease space spiked 290% in 2020 and fell by…
Many scientists from all over the world move to the United States to work and advance fundamental scientific understanding. A 2020 analysis conducted by the National Science Foundation showed that 46.2% of matriculating graduate students in science and engineering are international students. Even while at graduate and postdoctoral academic levels, these scientists contribute greatly to…